Ruger Accuses Beretta of Hostile Takeover Attempt, Reveals Demands for Discounted Shares and Board Control
RGR sits 35% above its 52-week low of $28.33 on light trading volume (0.2× avg).
Summary
Sturm, Ruger & Co. issued a strong press release accusing activist investor Beretta Holding S.A. of attempting a hostile takeover, detailing Beretta's demands for discounted stock and disproportionate board representation.
Key Events · Corporate Governance and Compliance · RGR
-
Hostile Takeover Accusation
Ruger publicly accused Beretta Holding S.A. of attempting a hostile takeover, stating Beretta's actions are not in the interest of all stockholders.
-
Demands for Discounted Stock
Ruger revealed Beretta repeatedly demanded the company issue additional shares at a 15% discount, which Ruger claims would dilute existing stockholders.
-
Demand for Board Control
Beretta sought disproportionate board representation and voting power, including appointing its own CEO to Ruger's Board, which Ruger states would violate U.S. antitrust laws.
-
Proxy Contest Escalation
This filing marks a significant public escalation in the ongoing proxy battle, providing Ruger's detailed counter-narrative to Beretta's director nominations filed on February 26, 2026.
Analysis · RGR · Manufacturing
This 8-K significantly escalates the ongoing proxy battle between Sturm, Ruger & Co. and its activist investor, Beretta Holding S.A. The company explicitly accuses Beretta of a hostile takeover attempt and reveals previously undisclosed, highly material demands, including a 15% discounted stock issuance and 25% ownership, which Ruger claims would dilute existing shareholders. Ruger also highlights Beretta's demand for board seats that would violate antitrust laws and its refusal to agree to a standstill. This public counter-attack, following the 10-K filing on March 2nd detailing a net loss and poison pill adoption, provides critical context for shareholders regarding the contentious nature of the dispute and the potential implications for corporate governance and shareholder value. Investors should closely monitor developments in this proxy fight, as its outcome will significantly influence the company's strategic direction and independence.
At the time of this filing, RGR was trading at $38.30 on NYSE in the Manufacturing sector, with a market capitalization of approximately $610.7M. The 52-week trading range was $28.33 to $48.21. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.